35 citations as recorded by crossref.

1. Unexpected Positive Cultures in Presumed Aseptic Revision Total Hip Arthroplasty P. Mirghaderi et al. 10.2106/JBJS.RVW.24.00137
2. Long acting anti-infection constructs on titanium S. Perni et al. 10.1016/j.jconrel.2020.06.013
3. Aspect ratio of nano/microstructures determines Staphylococcus aureus adhesion on PET and titanium surfaces A. Meinshausen et al. 10.1111/jam.15033
4. Prosthetic joint infection. A relevant public health issue E. Zardi & F. Franceschi 10.1016/j.jiph.2020.09.006
5. Prosthetic Joint Infections: Biofilm Formation, Management, and the Potential of Mesoporous Bioactive Glass as a New Treatment Option D. Almasri & Y. Dahman 10.3390/pharmaceutics15051401
6. Do Antibiotic-Loaded Calcium Sulfate Beads Improve Outcomes After Debridement, Antibiotics, and Implant Retention? A Matched Cohort Study T. Tarity et al. 10.1016/j.artd.2022.01.023
7. Hair removal with a clipper and microbial colonisation prior to knee arthroplasty: a randomised controlled trial T. Hasløv et al. 10.1016/j.infpip.2024.100377
8. Estimation of two-year hospital costs of hip and knee periprosthetic joint infection treatments using activity-based costing A. Hammat et al. 10.1302/0301-620X.106B10.BJJ-2024-0106.R1
9. Economic Study of 2-Stage Exchange in Patients With Knee or Hip Prosthetic Joint Infection Managed in a Referral Center in France: Time to Use Innovative(s) Intervention(s) at the Time of Reimplantation to Reduce the Risk of Superinfection H. Serrier et al. 10.3389/fmed.2021.552669
10. Unsuspected Positive Cultures in Planned Aseptic Revision Knee or Hip Arthroplasty—Risk Factors and Impact on Survivorship J. Schwarze et al. 10.1016/j.arth.2022.02.054
11. Proteomic profile at the time of surgery correlates with disease stage and surgical outcome in periprosthetic joint infection K. O’Connor et al. 10.1128/mbio.01700-25
12. New Attempts to Inhibit Methicillin-Resistant Staphylococcus aureus Biofilm? A Combination of Daptomycin and Azithromycin Y. Zhou et al. 10.2147/IDR.S433439
13. Advancing of 3D-Printed Titanium Implants with Combined Antibacterial Protection Using Ultrasharp Nanostructured Surface and Gallium-Releasing Agents S. Maher et al. 10.1021/acsbiomaterials.1c01030
14. Periprosthetic Joint Infection C. Hardin & R. Patel 10.1056/NEJMra2203477
15. Geringes UKA-Implantationsvolumen, Komorbiditäten, männliches Geschlecht und die Implantation einer gekoppelten TKA sind Risikofaktoren für septische Revisionen nach Knieprothesenimplantation D. Szymski et al. 10.1007/s00132-024-04562-y
16. Debridement, antibiotics, and implant retention combined with direct intra-articular antibiotic infusion in patients with acute hematogenous periprosthetic joint infection of the knee P. Chaiyakit et al. 10.1186/s12891-021-04451-x
17. Synovialis folyadékból nyert extracellularis vesiculák proteomja és azok lehetséges funkciója befertőződött ízületi protézisekben I. Sallai et al. 10.1556/650.2024.32886
18. Antibiotic prophylaxis before tissue biopsy has no effect on culture results in presumed aseptic revision total hip arthroplasty J. De Groot et al. 10.5194/jbji-9-67-2024
19. Harnessing Cyclic di-GMP Signaling: A Strategic Approach to Combat Bacterial Biofilm-Associated Chronic Infections P. Snega Priya et al. 10.1007/s00284-025-04091-7
20. The health-economic burden of hip and knee periprosthetic joint infections in Europe V. Alt et al. 10.1302/2633-1462.63.BJO-2024-0225.R1
21. The Effect of Time Spent with a Dynamic Spacer on Clinical and Functional Outcomes in Two-Stage Revision Knee Arthroplasty F. Golgelioglu et al. 10.1007/s43465-020-00247-8
22. Direct Hospital Costs per Case of Periprosthetic Hip and Knee Joint Infections in Europe — A Systematic Review D. Szymski et al. 10.1016/j.arth.2024.01.032
23. Cost of septic and aseptic revision total knee arthroplasty: a systematic review C. Okafor et al. 10.1186/s12891-021-04597-8
24. Developing an antibiogram for empiric antibiotic prescribing for adult non-spinal orthopaedic infections in a developing world setting A. Arakkal et al. 10.1007/s00590-023-03718-4
25. Comparing the in Vitro Efficacy of Commonly Used Surgical Irrigants for the Treatment of Implant-Associated Infections C. Hamad et al. 10.2106/JBJS.24.01225
26. Additively manufactured Ti–Ta–Cu alloys for the next-generation load-bearing implants A. Bandyopadhyay et al. 10.1088/2631-7990/ad07e7
27. Early Debridement, antibiotics and implant retention (DAIR) in patients with suspected acute infection after hip or knee arthroplasty - safe, effective and without negative functional impact L. Barros et al. 10.7150/jbji.39168
28. Comparison of the success rate after debridement, antibiotics and implant retention (DAIR) for periprosthetic joint infection among patients with or without a sinus tract W. Deng et al. 10.1186/s12891-021-04756-x
29. Debridement, antimicrobial therapy, and implant retention (DAIR) as curative strategy for acute periprosthetic hip and knee infections: a position paper of the European Bone & Joint Infection Society (EBJIS) I. Sigmund et al. 10.5194/jbji-10-101-2025
30. Local antibiotic treatment with calcium sulfate as carrier material improves the outcome of debridement, antibiotics, and implant retention procedures for periprosthetic joint infections after hip arthroplasty – a retrospective study K. Reinisch et al. 10.5194/jbji-7-11-2022
31. A Microcurrent Dressing Reduces Cutibacterium Acnes Colonization in Patients Undergoing Shoulder Arthroplasty or Arthroscopy: A Prospective Case Series B. Miller et al. 10.1177/15563316221100989
32. Comorbidity Index as a Risk Factor of Knee PJI Recurrence After Spacer Implantation P. Preobrazhensky et al. 10.17816/2311-2905-1718
33. Addressing the Needs of the Rapidly Aging Society through the Development of Multifunctional Bioactive Coatings for Orthopedic Applications T. Mastnak et al. 10.3390/ijms23052786
34. Low implantation volume, comorbidities, male sex and implantation of constrained TKA identified as risk factors for septic revision in knee arthroplasty: A register‐based study from the German Arthroplasty Registry D. Szymski et al. 10.1002/ksa.12182
35. Activity of Phage and Vancomycin in a Murine Staphylococcus aureus Periprosthetic Joint Infection Model Managed With Debridement and Implant Retention S. Herren et al. 10.1002/jor.70029